focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity, PDMR Dealing and TVR

21 Oct 2020 18:18

RNS Number : 8440C
Applied Graphene Materials PLC
21 October 2020
 

21 October 2020

Applied Graphene Materials plc

("Applied Graphene Materials" or "the Company")

Issue of Equity, PDMR Dealing and Total Voting Rights

Applied Graphene Materials (LSE: AGM) (OTCQB: APGMF), the producer of specialty graphene materials, confirms that 59,296 ordinary shares of 2 pence each ("Ordinary Shares") have been issued by the Company in partial settlement of the annual bonus due to David Blain, Chief Financial Officer, as determined by the Company's Remuneration Committee. The Ordinary Shares have been issued at a deemed price of 34.8 pence per share, being the average of the daily closing share prices for the period from 14 October 2020 (being the date of announcement of the Company's results for the year ended 31 January 2020) to 16 October 2020. The Ordinary Shares issued to Mr Blain have all been sold at a price of 31.5 pence per share and therefore Mr Blain's holding remains unchanged at 33,380 Ordinary Shares, representing 0.07% of the total voting rights in the Company.

Application has been made to the London Stock Exchange for admission of 59,926 Ordinary Shares to trading on AIM and dealings are expected to commence on 23 October 2020 ("Admission"). Following Admission, the Company will have a total of 49,704,292 Ordinary Shares in issue with voting rights. The Company does not hold any Ordinary Shares in treasury. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

For further information, please contact:

Applied Graphene Materials +44 (0) 1642 438 214

Adrian Potts, Chief Executive Officer

David Blain, Chief Financial Officer

 

Hudson Sandler +44 (0) 207 796 4133

Charlie Jack / Emily Dillon

 

N+1 Singer +44 (0) 207 496 3000

Peter Steel / Amanda Gray

 

Notes to Editors

For the last decade, Applied Graphene Materials has been at the forefront of harnessing the possibilities of graphene. Founded originally by Professor Karl Coleman, the Group has grown from an academic idea from Durham University to a world leader in the development and application of graphene nanoplatelet dispersions for customers in the coatings, composites and functional materials sectors.

 

The Group utilises its proprietary bottom-up manufacturing process to produce high purity graphene nanoplatelets. Their expertise in dispersion chemistry enables the Group to create optimised, stable and easy to handle dispersions that customers use in real-world industrial products. The Group's unique approach enables industries to fully realise the potential of graphene in a simple, safe and easy to formulate way.

 

The Group, based at the Wilton Centre on Teesside, was admitted to AIM in November 2013, raising £11 million. The Group successfully raised £8.5m in January 2016 and a further £9.8m in November 2017. Since August 2020, the Group's shares are also listed on OTCQX in the United States. As a result of the funding support and their industry leading technology platform, the Group has been able to develop a significant sales distribution network covering Europe, North America and a partner in Japan. The Group continues to work closely with industrial partners, and have seen the successful launch of numerous commercial products enhanced by their Graphene Dispersions.

https://www.appliedgraphenematerials.com/

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

David Blain

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Applied Graphene Materials plc

b)

 

LEI

 

 

213800OA661EWZOW5253

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.02 each

Identification code

GB00BFSSB742

 

b)

 

Nature of the transaction

 

 

1. Issue of Ordinary Shares in partial settlement of annual bonus

2. Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

 

1. Issue of Ordinary Shares in partial settlement of annual bonus

2. Sale of Ordinary Shares

 

34.8 pence

 

 

 

31.5 pence

59,296

 

 

 

59,296

 

 

 

 

 

d)

 

Aggregated information

- Aggregated volume

In respect of 1 and 2 in 4(c): N/A - single transactions

- Price

e)

 

Date of the transaction

 

 

In respect of:

1. 19 October 2020

2. 21 October 2020

f)

 

Place of the transaction

 

 

In respect of 1: outside a trading venue; in respect of 2: London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFEIFWFESSEFS
Date   Source Headline
25th Apr 20187:00 amRNSIssue of share options to Directors
18th Apr 20188:41 amRNSHolding(s) in Company
10th Apr 20187:00 amRNSInterim Results
8th Mar 20187:00 amRNSCollaboration with SHD and Magna Exteriors
1st Feb 20187:00 amRNSBoard Change
15th Jan 20189:22 amRNSHolding(s) in Company
10th Jan 20185:30 pmRNSHolding(s) in Company
10th Jan 20184:40 pmRNSSecond Price Monitoring Extn
10th Jan 20184:35 pmRNSPrice Monitoring Extension
8th Jan 20181:21 pmRNSHolding(s) in Company
4th Jan 20187:00 amRNSResult of AGM
3rd Jan 20187:00 amRNSAGM Statement
12th Dec 20177:00 amRNSNotice of AGM
7th Nov 20179:47 amRNSHolding(s) in Company
2nd Nov 20177:00 amRNSDirector/PDMR Shareholding
30th Oct 20171:15 pmRNSResults of Open Offer and General Meeting
12th Oct 20175:19 pmRNSPosting of Circular and Notice of General Meeting
10th Oct 20176:16 pmRNSFurther Details on the Fundraising
10th Oct 201711:41 amRNSClose of Accelerated Bookbuild
10th Oct 201711:00 amRNSPrice Monitoring Extension
10th Oct 20177:05 amRNSProposed Placing by Accelerated Bookbuild
10th Oct 20177:00 amRNSPreliminary Results
22nd Aug 20177:00 amRNSInvestor Site Visit
24th May 20177:00 amRNSNew Graphene Delivery Technology & Trading Update
22nd May 20174:18 pmRNSIssue of Equity and Total Voting Rights
26th Apr 20174:35 pmRNSPrice Monitoring Extension
11th Apr 20177:00 amRNSInterim Results
7th Apr 20174:40 pmRNSSecond Price Monitoring Extn
7th Apr 20174:35 pmRNSPrice Monitoring Extension
5th Apr 20174:40 pmRNSSecond Price Monitoring Extn
5th Apr 20174:35 pmRNSPrice Monitoring Extension
1st Feb 20177:00 amRNSGrant of Options
30th Jan 20177:00 amRNSShare Purchase by CFO-Designate
25th Jan 20177:00 amRNSBoard & Operational Appointments
20th Dec 20167:00 amRNSAGM Statement
31st Oct 20167:01 amRNSDirector/PDMR Shareholding
31st Oct 20167:00 amRNSDirectorate Change
17th Oct 20167:00 amRNSFinal Results
14th Oct 20167:00 amRNSFirst Production Order
12th Aug 20167:38 amRNSExercise of Share Options and PDMR Dealing
12th Aug 20167:00 amRNSDirectorate Change
12th Aug 20167:00 amRNSPeriod end trading update and notice of results
8th Aug 20167:00 amRNSProduct Development and New JDA
23rd Mar 20167:00 amRNSInterim Results
26th Jan 20163:21 pmRNSHolding(s) in Company
26th Jan 201612:15 pmRNSResult of AGM
25th Jan 20167:00 amRNSAGM Statement
22nd Jan 201610:33 amRNSHolding(s) in Company
13th Jan 20169:08 amRNSHolding(s) in Company
11th Jan 20163:42 pmRNSIssue of share options to Directors

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.